Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
10/2009
10/15/2009CA2721071A1 Methods and use of inducing apoptosis in cancer cells
10/15/2009CA2721025A1 Thienopyridone derivatives as amp-activated protein kinase (ampk) activators
10/15/2009CA2720946A1 Compounds and compositions as protein kinase inhibitors
10/15/2009CA2720616A1 Treatment of tumours
10/15/2009CA2720552A1 Acylthiourea compound or salt thereof, and use thereof
10/15/2009CA2719924A1 Cd37 immunotherapeutic and combination with bifunctional chemotherapeutic thereof
10/15/2009CA2719650A1 Bicyclic nitrogen-containing heterocyclic compounds for use as stearoyl coa desaturase inhibitors
10/15/2009CA2719538A1 Gem-disubstituted and spirocyclic amino pyridines/pyrimidines as cell cycle inhibitors
10/15/2009CA2719376A1 2h-benzo[b][1,4]oxazin-3(4h)-one derivatives for use as stearoyl coa desaturase inhibitors
10/15/2009CA2719295A1 Modified hydroxypolymer conjugates with bone seeking and tumor killing moieties
10/15/2009CA2718544A1 Crystalline salt forms of antifolate compounds and methods of manufacturing thereof
10/15/2009CA2718330A1 Antifolate compositions
10/15/2009CA2710554A1 Methods and compositions related to internalizing rgd peptides
10/15/2009CA2710398A1 Methods and compositions for targeting polyubiquitin
10/14/2009EP2108698A1 Vascular endothelial cell-binding peptide
10/14/2009EP2108658A1 Uses of IL-23 agonists and antagonists; related reagents
10/14/2009EP2108655A1 Immune-modulating peptide
10/14/2009EP2108645A1 Use of xanthone derivatives as a medicament for cancer
10/14/2009EP2108642A1 Jak inhibitor
10/14/2009EP2108378A2 Non-covalent bioconjugates useful for diagnosis and therapy
10/14/2009EP2108377A1 Vascularization inhibitors
10/14/2009EP2108373A1 Treatment of tumor metastases
10/14/2009EP2108370A1 Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent
10/14/2009EP2108368A1 Poly(glutamic acid)-drug conjugate with an amino acid as a linker
10/14/2009EP2108362A2 Method of producing a cationic liposomal preparation comprising a lipophilic compound
10/14/2009EP2108020A2 1-h-pyrazolo[3,4b]pyrimidine derivatives and their use as modulators of mitotic kinases
10/14/2009EP2108019A2 1-h-pyrazolo[3,4b]pyrimidine derivatives and their use as modulators of mitotic kinases
10/14/2009EP2108017A2 Imidazolone compounds as tgf-beta family type i receptors, alk5 and/or alk4 antagonists
10/14/2009EP2108016A1 2-anilino-4-heteroaryl pyrimidine derivatives, and preparation thereof as medicaments, pharmaceutical compositions, and in particular ikk inhibitors
10/14/2009EP2108014A1 Method of preparing docetaxel and intermediates used therein
10/14/2009EP2107906A2 Novel therapeutic use for treating leukaemia
10/14/2009EP1959985B1 Use of prolactin in the prophylactic treatment of cancer
10/14/2009EP1833830B1 Quinoline derivative, use and production thereof, and drug containing the same
10/14/2009EP1819331B1 Combinations comprising epothilones and protein tyrosine kinase inhibitors and pharmaceutical uses thereof
10/14/2009EP1755604B1 Use of opioid receptor antagonist compounds for the prevention and/or treatment of diseases associated with the target calcineurin
10/14/2009EP1732569B1 Use of adefovir or tenofovir for inhibiting mmtv-like viruses involved in breast cancer and primary biliary cirrhosis
10/14/2009EP1680449B1 Non-human transgenic mammal for the constant region of the class a human immunoglobulin heavy chain and applications therof
10/14/2009EP1658267B1 Inhibitors of cathepsin s
10/14/2009EP1594858B1 Novel benzoimidazole derivatives useful as antiproliferative agents
10/14/2009EP1554572B1 Compositions and methods for modulating blood-brain barrier transport
10/14/2009EP1432737B1 Human mini-antibody cytotoxic for tumor cells which express the erbb2 receptor
10/14/2009EP1397137B1 Hydantion derivatives as inhibitors of matrix metalloproteinases
10/14/2009EP1390343B1 Novel retinoid derivatives and an anti-cancer pharmaceutical composition comprising said compounds
10/14/2009EP1356046B1 Cytokine receptor zcytor19
10/14/2009EP1337527B1 Indolylmaleimide derivatives as protein kinase c inhibitors
10/14/2009EP1331950B1 Ex vivo methods and compositions for nucleic acid delivery
10/14/2009EP1232257B1 Modular transport systems for molecular substances and production and use thereof
10/14/2009EP1230268B1 Heteroclitic analogs of class i epitopes
10/14/2009EP1227843B1 Method and system to remove cytokine inhibitor in patients
10/14/2009EP1153129B1 Method of treating restenosis by antisense targeting of c-myc
10/14/2009EP0941227B2 Epothilone d, production process, and its use as cytostatic as well as phytosanitary agent
10/14/2009EP0734251B1 Method of transmitting a biologically active material to a cell
10/14/2009CN101558308A Methods of treating, diagnosing or detecting cancer
10/14/2009CN101558080A Modulation of angiogenesis by a-beta peptide fragments
10/14/2009CN101558074A Epothilone analogues modified at positions C12-C13 as anticancer drugs
10/14/2009CN101558070A Triazolo-pyridazine protein kinase modulators
10/14/2009CN101558069A Cis-cyclohexyl substituted pyrimidinone derivatives
10/14/2009CN101558068A Phenylacetamides useful as protein kinase inhibitors
10/14/2009CN101558051A Method of preparing docetaxel and intermediates used therein
10/14/2009CN101558049A Substituted pyrazole and triazole compounds as KSP inhibitors
10/14/2009CN101558046A Morpholino pyrimidine derivatives useful in the treatment of proliferative disorders
10/14/2009CN101558041A Caspase inhibitors based on pyridazinone scaffold
10/14/2009CN101555486A Application of human transcription factor HMBOX1 gene
10/14/2009CN101555469A High-efficiency recombined adenovirus containing ndrg2 gene and pharmic purpose thereof
10/14/2009CN101555291A Extraction and separation technology of ginseng polysaccharides
10/14/2009CN101555283A Antibodies to non-functional p2x7 receptor, diagnosis and treatment of cancers and other conditions
10/14/2009CN101555273A Ligand polypeptide combined with Tie2 protein specificity and drug delivery system
10/14/2009CN101555267A Synthesis method of clofarabine of nucleoside analogues
10/14/2009CN101555264A Derivative of highly active tetra cyclic anthroquinones antibiotics and preparation and application thereof
10/14/2009CN101555250A Preparation method of topotecan hydrochloride
10/14/2009CN101555245A Application of silibinin methyl ether in preparing anti-leukemia medicine
10/14/2009CN101555241A Ampelopsin pro-dug and preparing method and application thereof
10/14/2009CN101554479A Pharmaceutical composition containing an iron-binding agent
10/14/2009CN101554472A Novel medical compound being capable of synergetically suppressing growth of tumors
10/14/2009CN101554462A Medicament for curing cancer
10/14/2009CN101554456A Traditional Chinese medicine for treating cancer
10/14/2009CN101554417A Quality control method of antitumor Chinese medicine composition
10/14/2009CN101554416A Chinese medicine composition and preparation method and application thereof
10/14/2009CN101554409A Long pepper alkaloid and preparation method, preparation and application thereof
10/14/2009CN101554392A Medical prescription of new medicine ester glycosides capsule for treating tumour and preparation technique thereof
10/14/2009CN101554388A Cinobufagin injection effective component and use thereof in preparation of antineoplastic drug
10/14/2009CN101554384A Method for preparing realgar injection and use thereof
10/14/2009CN101554364A Bulleyaconitine A micro-balloons and bulleyaconitine A long-acting injection and preparation method and application of same
10/14/2009CN100549179C Stomach cancer target AFP gene siRNAs expression vector and its uses
10/14/2009CN100549175C Recombinant protein with cancer suppression action and its encoding gene and use
10/14/2009CN100549164C Recombinant virus comprising tumor therapeutic full-antibody gene with human constant region and its use
10/14/2009CN100549011C Novel imidazopyridines as cyclin dependent kinase inhibitors
10/14/2009CN100549008C Substituted oxazolidinones and their use in the field of blood coagulation
10/14/2009CN100549006C Mitotic kinesin inhibitors
10/14/2009CN100548996C 5-phenylthiazole derivatives and its use for preparing medicine
10/14/2009CN100548988C Metabolites of ecteinascidin 743
10/14/2009CN100548940C One and two step ultracritical fluid extraction of carotene, VE and other trace element concentration
10/14/2009CN100548383C Method and compositions for prevention or treatment of cancer
10/14/2009CN100548377C Vaccine composition containing modified dendritic cells
10/14/2009CN100548375C Antitumor effect potentiators
10/14/2009CN100548373C Vaccines
10/14/2009CN100548337C Medicine for treating leukemia and preparation method thereof
10/14/2009CN100548331C Compound cape-jasmine salted-fermented beans total extract and its preparation and use
10/14/2009CN100548329C Drugs including immunopotentiators and health foods and drinks
10/14/2009CN100548323C Medical composition prepared by Gynostemma pentaphylla, American ginseng and astragalus root
1 ... 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 ... 2211